SEC Form 4 · accession 0001437749-16-043352
Sun BioPharma, Inc. · SNBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul W. Schaffer
Director
Period of report
Dec 12, 2016
Accepted (ET)
Dec 14, 2016 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.51 | Dec 12, 2016 | A | 208,000 | A | — | Dec 12, 2026 | Common Stock | 208,000 | 208,000 | D |
| Stock Option (right to buy)F2 | $1.51 | Dec 12, 2016 | A | 160,000 | A | — | Dec 12, 2026 | Common Stock | 160,000 | 160,000 | D |
Explanation of responses
- F1Options scheduled to vest as to 50% of the shares on December 12, 2016 and as to 25% of the shares on each of June 12, 2017 and December 12, 2017.
- F2Options scheduled to vest in eight equal installments on the last day of each calendar quarter, starting March 31, 2017.